EUVIMEDEUVIMED entdecken
Crossref

In vitro activity of gepotidacin against a challenging panel of multidrug-resistant Neisseria gonorrhoeae isolates

Michelle Jayne Cole iD, Michel Doumith, Anna Vickers, Sarah Alexander iD, Helen Fifer iD, Michaela Day, Charles Jakielaszek, Nicole Scangarella-Oman, Rachel Pitt-Kendall

Journal of Antimicrobial Chemotherapy · 2026

DOI: 10.1093/jac/dkag001 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Antimicrobial Chemotherapy, 2026. Verfasst von Michelle Jayne Cole und 8 weiteren Autor:innen. Beteiligte Einrichtung: Blood Safety, Hepatitis, STI & HIV Division, UK Health Security Agency, London, UK. Hauptthemen laut MEDLINE: Neisseria gonorrhoeae, Anti-Bacterial Agents, Acenaphthenes, Drug Resistance, Multiple, Bacterial. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 24 Literaturangaben. Gefördert von: GSK.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

Gepotidacin is a novel triazaacenaphthylene topoisomerase inhibitor that has demonstrated non-inferiority to 500 mg of intramuscular ceftriaxone plus 1 g of oral azithromycin for the treatment of uncomplicated urogenital gonorrhoea. We evaluated gepotidacin in vitro activity against a panel of ceftriaxone-resistant Neisseria gonorrhoeae isolates that were referred to the UK Health Security Agency between 2015 and 2023.

Methods

Gepotidacin and comparator antimicrobials were tested against 23 ceftriaxone-resistant (MIC ≥0.25 mg/L) N. gonorrhoeae isolates by agar dilution. Genomic sequences were examined for known resistance determinants and sequence types.

Results

Gepotidacin inhibited the majority (96%) of isolates at ≤2 mg/L, with MIC range, MIC50 and MIC90 values of 0.25–4, 0.5 and 2 mg/L, respectively. All 23 isolates had amino-acid modifications associated with ciprofloxacin resistance, including the rare GyrA A92P alteration in 10 isolates, none of which are believed to effect gepotidacin binding. All isolates had mutations causing the overexpression of the MtrCDE efflux pump and 10 isolates had mutations causing the overexpression of the NorM efflux pump. Nine different MLSTs were subdivided into 16 and 14 NG-MAST and NG-STAR types, respectively. MLST ST8123 was the most prevalent MLST and the gepotidacin MIC range against this sequence type was similar to the overall distribution.

Conclusion

Overall, gepotidacin was active in vitro against this challenging panel of ceftriaxone-resistant gonococcal clinical isolates. Gepotidacin activity does not seem to be affected in this ceftriaxone-resistant set of strains. A structural analysis suggests that the rare GyrA A92P alteration identified in this study does not affect gepotidacin binding.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Neisseria gonorrhoeaeAnti-Bacterial AgentsAcenaphthenesDrug Resistance, Multiple, BacterialHeterocyclic Compounds, 3-RingMicrobial Sensitivity TestsHumansGonorrheaCeftriaxoneUnited Kingdom

Substanzen

gepotidacinAnti-Bacterial AgentsAcenaphthenesHeterocyclic Compounds, 3-RingCeftriaxone

Autor:innen und Institutionen

  • Blood Safety, Hepatitis, STI & HIV Division, UK Health Security Agency, London, UK.
  • Public Health Microbiology, UK Health Security Agency, London, UK.
  • Infectious Disease Research, GSK, Collegeville, PA, USA.

ORCID-Profile: Michelle Jayne Cole, Sarah Alexander, Helen Fifer

Förderung

  • GSK

Zitieren

APA

Cole, M. J., Doumith, M., Vickers, A., Alexander, S., Fifer, H., Day, M., Jakielaszek, C., Scangarella-Oman, N., & Pitt-Kendall, R. (2026). In vitro activity of gepotidacin against a challenging panel of multidrug-resistant Neisseria gonorrhoeae isolates. Journal of Antimicrobial Chemotherapy. https://doi.org/10.1093/jac/dkag001

Vancouver

Cole MJ, Doumith M, Vickers A, Alexander S, Fifer H, Day M, et al. In vitro activity of gepotidacin against a challenging panel of multidrug-resistant Neisseria gonorrhoeae isolates. Journal of Antimicrobial Chemotherapy. 2026. doi:10.1093/jac/dkag001

BibTeX
@article{Cole2026,
  author = {Cole, Michelle Jayne and Doumith, Michel and Vickers, Anna and Alexander, Sarah and Fifer, Helen and Day, Michaela and Jakielaszek, Charles and Scangarella-Oman, Nicole and Pitt-Kendall, Rachel},
  title = {In vitro activity of gepotidacin against a challenging panel of multidrug-resistant Neisseria gonorrhoeae isolates},
  journal = {Journal of Antimicrobial Chemotherapy},
  year = {2026},
  doi = {10.1093/jac/dkag001}
}
Kostenlos starten →